Too many lung cancer cases are diagnosed late-stage1— or not at all.

But we believe that can change.

Through partnership and a shared vision, we can use advanced diagnostics and minimally invasive surgical solutions to turn lung cancer into a more manageable and treatable disease.2–4

 

United to improve lung health care and patient outcomes

As early identification of patients increases through expanded screening eligibility and nodule identification, we envision a future when lung cancer in most patients is found at an early stage.

We are your partner for proven solutions with clinical, economical, and operational advantages — supporting the biopsy stage and providing tools for minimally invasive thoracic surgery.

Doctor examines patient with stethoscope

Lung health and thoracic surgery product portfolio

Our goal is always the same: to get patients back to doing what they love — as quickly and safely as possible. We’re committed to innovating technology that optimizes outcomes for patients with lung cancer, esophageal cancer, and other diseases of the chest.


Your thoracic partner of choice


See a graphic showing the Medtronic products that support the thoracic care pathway.

Do not tie knots in the V-loc™ wound closure device. Tying knots may damage the barbs and potentially reduce their effectiveness. Please see the full Indications for use (IFU) for details.

The Medtronic Touch Surgery™ ecosystem is not intended to direct surgery, or aid in diagnosis or treatment of a disease or condition. Please note: Performance Insights are available for select procedures, instruments, and anatomy.


Featured products

The ILLUMISITE™ platform is designed to correct for CT-to-body divergence — the discrepancy between a static CT scan and the breathing lung — with real-time visualization that enhances image clarity and adjusts to a dynamic environment.†,5–7

The LigaSure™ Maryland jaw thoracic device is the first minimally invasive LigaSure™ device indicated for sealing pulmonary veins and arteries up to and including 7 mm.‡,8

Explore the Signia™ powered stapler with Tri-Staple™ technology. The Signia™ powered stapler adjusts firing speed based on force feedback during clamp and firing to optimize stapling formation and deliver consistent staple lines.§,9,10 



Bedside stapling during robotic-assisted surgery (RAS) thoracic procedures

Medtronic staplers used in robotic-assisted surgery (RAS) procedures are associated with a lower occurrence of bleeding, shorter operating room (OR) time, and lower costs compared to SureForm™* staplers.◊,¶,11,12


Product image of the purple 60 mm Tri-Staple™ 2.0 Cartridge for the Signia™ stapling system.

Risks may include, but are not limited to: acute/chronic pain, bleeding, infection, and tissue damage. Please see the indications for use (IFU) for more information.

Tri-Staple™ 2.0 purple reload

When used with the Signia™ stapler, Tri-Staple™ 2.0 reloads give surgeons more reload options for real-time feedback during clamping and firing.13

Risks may include, but are not limited to: bleeding, anastomotic leaks, infection, tissue damage, and perforation.  Please see the indications for use (IFU) for more information.

Lower occurrence of bleeding

Medtronic bedside staplers are associated with a 44% reduced relative incidence of bleeding when compared to SureForm™* staplers in robotic thoracic procedures.◊,11

Reduced operating room time

See a magenta circle clock icon.

Medtronic bedside staplers are associated with 25 minutes shorter OR times than SureForm™* staplers in robotic lobectomy procedures.¶,12

Reduced cost

See a magenta circle icon showing the dollar down.

Medtronic bedside staplers are associated with $7,024 lower inpatient costs than SureForm™* staplers in robotic lobectomy procedures.¶,12

Risks may include, but are not limited to: bleeding, anastomotic leaks, infection, tissue damage, and perforation. Please see the indications for use (IFU) for more information.




Lung cancer patient information

Download an informational guide to help patients understand the diagnosis, staging, and surgical treatment options for lung cancer.

Western Colorado Active Seniors Mature Adult Couple Outdoors Playing Pickleball on a Sunny Late Spring Day Photo Series
See a group of doctors meeting and taking notes.

Lung cancer is complicated and costly — for patients, clinicians, and healthcare systems.

We share your mission to cut through the complexity, improve patient outcomes, and reduce the cost of care. Our thoracic surgery solutions are built upon:

  • Clinical evidence: We have proven solutions that help provide a better patient experience.
  • Operational efficiencies: We offer products engineered to meet your needs and provide support to take you to new heights.

Not for use in pediatric patients or those with unstable hemodynamic status. Specific risks include but not limited to: bleeding, pneumothorax, and respiratory failure. Please refer to the indications for use (IFU) for complete contraindication and risk information for each product.

™* Third-party brands are trademarks of their respective owners. 

† Based on evidence from a single-center prospective study including a total of 82 consecutive patients.

‡ As of March 23, 2018, based on indications for use for laparoscopic LigaSure™ devices.

§ Preclinical results may not correlate with clinical performance in humans.

◊ Medtronic stapler adjusted bleeding rate = 3.1%, SureForm™‑adjusted bleeding rate = 5.6%, p = 0.003. Data extracted from Premier Healthcare Database, 2021–2022. Medtronic bedside staplers inclusive of Signia™, Tri‑Staple™, and other Medtronic staplers. 

¶ p<0.001. Data extracted from Premier Healthcare Database, 2021–2022. Medtronic bedside staplers inclusive of Signia™, Tri‑Staple™, and other Medtronic staplers.

  1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan–Feb;74(1):12–49. doi: 10.3322/caac.21820. Epub 2024 Jan 17. Erratum in: CA Cancer J Clin. 2024 Mar–Apr;74(2):203. doi: 10.3322/caac.21830. PMID: 38230766.
  2. Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res. 2017;9:261–269.
  3. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763–1771.
  4. LeMense GP, Waller EA, Campbell C, Bowen T. Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program. BMC Pulm Med. 2020;20(1):115. doi:10.1186/s12890-020-1129-7.
  5. Pritchett MA, Bhadra K, Calcutt M, Folch E. Virtual or reality: divergence between preprocedural computed tomography scans and lung anatomy during guided bronchoscopy. J Thorac Dis. 2020;12(4):1595–1611.
  6. Pritchett MA, Bhadra K, Mattingley JS. Electromagnetic navigation bronchoscopy with tomosynthesis-based visualization and positional correction: three-dimensional accuracy as confirmed by cone-beam computed tomography. J Bronchology Interv Pulmonol. 2021; 28(1):10–20.
  7. Avasarala SK, Roller L, Katsis J, et al. Sight unseen: diagnostic yield and safety outcomes of a novel multimodality navigation bronchoscopy platform with real-time target acquisition. Respiration. 2022;101(2):166–173. doi: 10.1159/000518009.
  8. Based on internal report RE00147462, Pulmonary sealing claims for the LigaSure™ Maryland jaw thoracic LF1930T device (memo). March 28, 2018.
  9. Based on internal test report R2146-173-0, ASA verification testing with slow speed force limit evaluation. 2015.
  10. Based on internal test report R2146-151-0, Powered stapling firing speed DOE analysis and ASA parameters. 2015.
  11. Pan et al, The Evaluation of Surgical Stapling in Robotic Thoracic Procedures — Clinical Outcomes and Resource Utilization. Poster presentation from ISPOR Europe 2024.
  12. Lazar et al, Clinical and financial impact of stapler choice in robotic lobectomy: A premier database analysis. Poster presentation from STS 2025.
  13. Signia™ stapling system [user manual, PT00032755]. Mansfield, MA: Covidien; 2016.